Principles of early drug discovery
Explore this paper's citation graph
Summary
This review will look at key preclinical stages of the drug discovery process, from initial target identification and validation, through assay development, high throughput screening, hit identification, lead optimization and finally the selection of a candidate molecule for clinical development.
- Type
- review
- Published
- 2011-03-01
- Cited by
- 2,496
- References
- 25
- Access
- Open access
- OpenAlex
- https://openalex.org/W1500036797
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:5496647
Keywords
Drug discovery, Identification (biology), Process (computing), Computer science, Risk analysis (engineering)
References
- Recombinant aequorin as reporter of changes in intracellular calcium in mammalian cells.
- Knocking down barriers: advances in siRNA delivery
- The function neutralizing anti-TrkA antibody MNAC13 reduces inflammatory and neuropathic pain
- A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays
- The multiple roles of computational chemistry in fragment-based drug design
- HTS and hit finding in academia – from chemical genomics to drug discovery
- Probes for chemical genomics by design.
- Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses
- What constitutes target validation
- Analgesic profile of intrathecal P2X3 antisense oligonucleotide treatment in chronic inflammatory and neuropathic pain states in rats
- The promises and pitfalls of RNA-interference-based therapeutics
- Cell-based assays: fuelling drug discovery
- Virtual screening strategies in drug discovery.
- Cell-Based Versus Isolated Target Screening: How Lucky Do You Feel?
- Target discovery from data mining approaches.
- Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain
- Comprehensive screening for antigens overexpressed on carcinomas via isolation of human mAbs that may be therapeutic
- Knowledge based identification of MAO-B selective inhibitors using pharmacophore and structure based virtual screening models.
- Approaches to measuring the activities of protein arginine N-methyltransferases
- Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia
Cited by
- New delivery systems for amphotericin B applied to the improvement of leishmaniasis treatment.
- Review: Basics of Drug Development in Rheumatology
- Polypharmacology Shakes Hands with Complex Aetiopathology.
- Intracellular quantitative detection of human thymidylate synthase engagement with an unconventional inhibitor using tetracysteine-diarsenical-probe technology
- Preclinical mouse model to monitor live Muc5b-producing conjunctival goblet cell density under pharmacological treatments
- Protein degradation: a validated therapeutic strategy with exciting prospects.
- The Molecular Design Research Network
- Where Do Recent Small Molecule Clinical Development Candidates Come From?
- Making Sense of Pharmacology: Inverse Agonism and Functional Selectivity
- Potential Anti-Cancer Flavonoids Isolated From Caesalpinia bonduc Young Twigs and Leaves: Molecular Docking and In Silico Studies
- Computational drug repurposing in the age of COVID-19: mixing antiviral cocktails in silico
- Recent progress on structural bioinformatics research of cytochrome P450 and its impact on drug discovery.
- Novel antiviral strategies for feline coronavirus and feline calicivirus
- Structure-based drug discovery against a novel antimalarial drug target, S-adenosylmethionine decarboxylase/ornithine decarboxylase
- Entwicklung von Teststrategien zur selektiven Hemmung von Enzymen der adrenalen Steroidsynthese unter besonderer Berücksichtigung von Speziesunterschieden
- Every Silver Lining has a Cloud: The Scientific and Animal Welfare Issues Surrounding a New Approach to the Production of Transgenic Animals
- Finding new scaffolds of JAK3 inhibitors in public database: 3D-QSAR models & shape-based screening
- Anti-diabetic effects of oleanolic acid and matrine
- Novel insight into drug repositioning: Methylthiouracil as a case in point.
- Design, synthesis and anticancer properties of novel oxa/azaspiro[4,5]trienones as potent apoptosis inducers through mitochondrial disruption.
Related papers
- Widening bottlenecks in drug discovery: glimpses from Drug Discovery Technology Europe 2005.
- Miniaturized drug discovery and high throughput microarrays for biological discovery
- Success rates for product development strategies in new drug development
- Human Pluripotent Stem-Cell-Derived Models as a Missing Link in Drug Discovery and Development
- Translational pharmacokinetic-pharmacodynamic analysis in the pharmaceutical industry: an IQ Consortium PK-PD Discussion Group perspective.